학술논문
PRO24 COST-EFFECTIVENESS OF LANADELUMAB AND C1-INHIBITORS FOR PROPHYLAXIS AGAINST ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA
Document Type
Abstract
Author
Source
In Value in Health May 2019 22 Supplement 2:S339-S339
Subject
Language
ISSN
1098-3015